MG
ANGO icon

Michael Gelband’s AngioDynamics ANGO Stock Holding History

Michael Gelband’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
+31,274
New +$356K ﹤0.01% 1288
2026
Q1 		– Sell
-47,402
Closed -$609K – 1532
2025
Q4 		$609K Buy
47,402
+31,845
+205% +$393K ﹤0.01% 1144
2025
Q3 		$174K Buy
+15,557
New +$150K ﹤0.01% 1401
2024
Q4 		– Sell
-63,960
Closed -$498K – 1487
2024
Q3 		$498K Sell
63,960
-953,874
-94% -$6.89M ﹤0.01% 1187
2024
Q2 		$6.16M Buy
1,017,834
+828,174
+437% +$5.11M 0.04% 350
2024
Q1 		$1.11M Sell
189,660
-439,943
-70% -$2.61M 0.01% 910
2023
Q4 		$4.94M Sell
629,603
-187,789
-23% -$1.3M 0.03% 346
2023
Q3 		$5.97M Buy
817,392
+644,316
+372% +$5.36M 0.06% 332
2023
Q2 		$1.8M Buy
+173,076
New +$1.67M 0.01% 852
2023
Q1 		– Sell
-19,604
Closed -$270K – 1729
2022
Q4 		$270K Buy
+19,604
New +$273K ﹤0.01% 1385
2021
Q4 		– Sell
-16,626
Closed -$431K – 2137
2021
Q3 		$431K Buy
+16,626
New +$445K 0.01% 1474
2021
Q1 		– Sell
-25,924
Closed -$397K – 2091
2020
Q4 		$397K Buy
+25,924
New +$329K ﹤0.01% 1384

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's ANGO Position: Q2 2026 in Review

Michael Gelband opened a new position in AngioDynamics (ANGO) in Q2 2026: 31,274 shares worth $407K. The stake represents ﹤0.01% of the portfolio and ranks #1288 among its holdings. This is a return to the name: Michael Gelband previously reported a position in ANGO as recently as Q4 2025.

Michael Gelband first reported a position in ANGO in Q4 2020 and has held it in 12 quarters since. The position peaked at $6.16M in Q2 2024. 160 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Michael Gelband held 31,274 shares of AngioDynamics worth $407K as of Q2 2026.
  • AngioDynamics was a new Michael Gelband position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1288 holding.
  • Michael Gelband first reported a position in AngioDynamics in Q4 2020 and has held it in 12 quarters since.
  • Michael Gelband's AngioDynamics position peaked at $6.16M in Q2 2024.
  • 160 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.